SCHEMBL29352444

SCHEMBL29352444

N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 6/20 0.58
▸ NAALAD2 Q9Y3Q0 4/20 0.58
▸ RIMKLA Q8IXN7 1/20 0.58
▸ GRM8 O00222 1/20 0.48
▸ GRM6 O15303 1/20 0.48
▸ GRIN2D O15399 1/20 0.48
▸ GRIN3B O60391 1/20 0.48
▸ GSR P00390 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ GRIK1 P39086 1/20 0.48
▸ GRM5 P41594 1/20 0.48
▸ GRIA1 P42261 1/20 0.48
▸ GRIA2 P42262 1/20 0.48
▸ GRIA3 P42263 1/20 0.48
▸ SLC1A3 P43003 1/20 0.48
▸ SLC1A2 P43004 1/20 0.48
▸ SLC1A1 P43005 1/20 0.48
▸ GRIA4 P48058 1/20 0.48
▸ GRIN1 Q05586 1/20 0.48
▸ GRIN2A Q12879 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29844310 1.00 FOLH1 (0.58) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL29539765 0.97 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL30193339 0.95 FOLH1 (0.53) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL30193271 0.95 FOLH1 (0.53) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL30040038 0.95 FOLH1 (0.53) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL28464431 0.94 FOLH1 (0.51) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL30040249 0.94 FOLH1 (0.51) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL28464429 0.94 FOLH1 (0.51) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL29873398 0.92 FOLH1 (0.49) FOLH1NAALAD2RIMKLAGRM8GRM6
SCHEMBL28686678 0.91 FOLH1 (0.49) FOLH1NAALAD2RIMKLAGRM8GRM6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026088246-A1 METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND NTT株式会社 2026-04-30 — — WO claimed
US-20250263437-A1 POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-08-21 — — US claimed
CN-117757792-A Nucleic acid interference medicine for treating liver injury 圣诺生物医药技术(苏州)有限公司 2024-03-26 — — CN claimed
EP-4276105-A1 POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) 2023-11-15 — — EP claimed
CN-114805489-A Polypeptide for repairing skin injury or mucous membrane injury and application thereof 四川好医生攀西药业有限责任公司 2022-07-29 — — CN claimed
WO-2022148289-A1 POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF 四川好医生攀西药业有限责任公司 2022-07-14 — — WO claimed
WO-2026088246-A1 METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND NTT株式会社 2026-04-30 — — WO disclosed
US-20250263437-A1 POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-08-21 — — US disclosed
CN-119685295-A Preparation method of acid-resistant high-activity keratinase preparation and application of acid-resistant high-activity keratinase preparation in feather meal fermented feed 江苏大学 2025-03-25 — — CN disclosed
CN-119530123-A Low-sodium salt-reducing and freshness-increasing metaplasia and preparation method and application thereof 内蒙古科拓生物有限公司 2025-02-28 — — CN disclosed
CN-119278942-A Composite antibacterial dressing, preparation method and application thereof in bone cultural relic protection material 四川大学 2025-01-10 — — CN disclosed
CN-119220557-A Rice nitrogen efficient utilization gene OsNAC15, protein coded by same and application thereof 东北农业大学 2024-12-31 — — CN disclosed
US-20240315296-A1 PEPTIDE COMPOUNDS FOR FLAVOR MODULATING CJ CHEILJEDANG CORPORATION (KR) 2024-09-26 — — US disclosed
EP-4013440-A1 THERAPEUTIC PEPTIDES Cohbar Inc. (US) 2022-06-22 — — EP disclosed
CN-114621194-A 4-methylene-N-hydroxybenzamide compound and application thereof 沈阳药科大学 2022-06-14 — — CN disclosed
US-11332497-B2 Therapeutic peptides COHBAR, INC. (US) 2022-05-17 — — US disclosed
WO-2022087224-A1 METHOD OF TREATING FIBROSIS WITH A COMBINATION THERAPY COHBAR, INC. (US) 2022-04-28 — — WO disclosed
CN-114269367-A Therapeutic peptides 科巴公司 2022-04-01 — — CN disclosed
CN-114225018-A TPP1 formulations and methods for treating CLN2 disease 生物马林药物股份有限公司 2022-03-25 — — CN disclosed
CN-107847615-B TPP1 formulations and methods for treating CLN2 disease 生物马林药物股份有限公司 2022-01-25 — — CN disclosed
Send feedback